Free Trial
→ Tomorrow morning's stock alert (From The Early Bird) (Ad)tc pixel Free TVGN Stock Alerts

Tevogen Bio (TVGN) Institutional Ownership

Tevogen Bio logo
$9.42 +2.65 (+39.14%)
Closing price 05/14/2026 04:00 PM Eastern
Extended Trading
$9.38 -0.04 (-0.37%)
As of 05:53 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Institutional Ownership Changes (13F Filings) for Tevogen Bio (NASDAQ:TVGN)

Number of
Institutional Buyers
(last 12 months)
3
Total
Institutional Inflows
(last 12 months)
$5.99M
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$1.26M
Get TVGN Insider Trade Alerts

Want to know when executives and insiders are buying or selling Tevogen Bio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

TVGN Institutional Buying and Selling by Quarter

Tevogen Bio Major Shareholders & Ownership History

Export
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/11/2026 Deutsche Bank AG173,734$57K0.0%+304.1%0.087%
2/10/2026Goldman Sachs Group Inc.273,694$91K0.0%+126.0%0.138%
11/14/2025Bridgeway Capital Management LLC82,500$65K0.0%+66.7%0.042%
5/16/2025Goldman Sachs Group Inc.54,761$59K0.0%-29.9%0.030%
5/12/2025Nuveen LLC90,253$97K0.0%N/A0.049%
2/14/2025Northern Trust Corp118,415$122K0.0%+13.0%0.068%
2/13/2025XTX Topco Ltd53,858$55K0.0%N/A0.031%
2/13/2025Barclays PLC45,600$48K0.0%+39.2%0.026%
2/12/2025Geode Capital Management LLC451,851$465K0.0%+31.2%0.258%
2/12/2025JPMorgan Chase & Co.39,207$40K0.0%+74.2%0.022%
1/24/2025China Universal Asset Management Co. Ltd.37,117$38K0.0%N/A0.021%
11/15/2024Polar Asset Management Partners Inc.1,577,387$581K0.0%-20.6%0.924%
11/15/2024HGC Investment Management Inc.223,077$82K0.0%N/A0.131%
5/9/2024Portland Global Advisors LLC5,782,209$21.68M3.0%N/A36.550%


TVGN Institutional Ownership - Frequently Asked Questions

During the previous two years, 12 institutional investors and hedge funds held shares of Tevogen Bio. The most heavily invested institutionals were Polar Asset Management Partners Inc. ($581K), Geode Capital Management LLC ($465K), Northern Trust Corp ($122K), Nuveen LLC ($97K), Goldman Sachs Group Inc. ($91K), HGC Investment Management Inc. ($82K), and Bridgeway Capital Management LLC ($65K).Learn more on Tevogen Bio's institutional investors.

Of the 11 institutional investors that purchased Tevogen Bio's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: HGC Investment Management Inc. ($223.08K), Goldman Sachs Group Inc. ($152.57K), Deutsche Bank AG ($130.74K), Geode Capital Management LLC ($107.57K), Nuveen LLC ($90.25K), XTX Topco Ltd ($53.86K), and China Universal Asset Management Co. Ltd. ($37.12K).

Institutional investors have bought a total of 316,310 shares in the last 24 months. This purchase volume represents approximately $5.99M in transactions.

The following institutional investors have sold Tevogen Bio stock in the last 24 months: Goldman Sachs Group Inc. ($23.40K).

Institutional investors have sold a total of 23,396 shares in the last 24 months. This volume of shares sold represents approximately $1.26M in transactions.


Related Companies

This page (NASDAQ:TVGN) was last updated on 5/15/2026 by MarketBeat.com Staff.
From Our Partners
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...
Paradigm Press | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Why this tiny stock may move before the SpaceX IPO drops
The projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...
Behind the Markets | Sponsoredtc pixel
Satellite Images Spot Potential $10 Trillion Discovery
'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...
Altimetry | Sponsoredtc pixel
SpaceX just filed. The clock is ticking.
Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...
The Oxford Club | Sponsoredtc pixel